Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Lees

Showing results (51-60 of 183) with videos related to

Pageof 19
Sort By:
Brain : a Journal of Neurology|February 15, 2002
Attention to action in Parkinson's disease: impaired effective connectivity among frontal cortical regionsJames Rowe, Klaas Enno Stephan, Karl Friston, et al.
Infection and Immunity|December 23, 2003
Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic miceRobert W Maitta, Kausik Datta, Andrew Lees, et al.
Translational Neurodegeneration|April 30, 2020
Correction to: Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label studyHeinz Reichmann, Andrew Lees, José-Francisco Rocha, et al.
Translational Neurodegeneration|April 30, 2020
Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label studyHeinz Reichmann, Andrew Lees, José-Francisco Rocha, et al.
The European Journal of Neuroscience|June 8, 2011
Improvements in rate of development and magnitude of force with intense auditory stimuli in patients with Parkinson's diseaseAnam Anzak, Huiling Tan, Alek Pogosyan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 14, 2011
The nature of an in vivo anti-capsular polysaccharide response is markedly influenced by the composition and/or architecture of the bacterial subcapsular domainSwadhinya Arjunaraja, Paola Massari, Lee M Wetzler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 7, 2011
Adult survivors of invasive pneumococcal disease exhibit defective B cell functionTom C Darton, James B Wing, Andrew Lees, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2006
Early piribedil monotherapy of Parkinson's disease: A planned seven-month report of the REGAIN studyOlivier Rascol, Bruno Dubois, Alexandre Castro Caldas, et al.
Neuroimage|October 19, 2004
Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's diseaseShona Price, Dominic Paviour, Rachael Scahill, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 29, 2018
Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicineMargherita Fabbri, Joaquim J Ferreira, Andrew Lees, et al.
Pageof 19

Showing results (51-60 of 183) with videos related to

Sort By:
Pageof 19
Brain : a Journal of Neurology|February 15, 2002
Attention to action in Parkinson's disease: impaired effective connectivity among frontal cortical regionsJames Rowe, Klaas Enno Stephan, Karl Friston, et al.
Infection and Immunity|December 23, 2003
Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic miceRobert W Maitta, Kausik Datta, Andrew Lees, et al.
Translational Neurodegeneration|April 30, 2020
Correction to: Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label studyHeinz Reichmann, Andrew Lees, José-Francisco Rocha, et al.
Translational Neurodegeneration|April 30, 2020
Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label studyHeinz Reichmann, Andrew Lees, José-Francisco Rocha, et al.
The European Journal of Neuroscience|June 8, 2011
Improvements in rate of development and magnitude of force with intense auditory stimuli in patients with Parkinson's diseaseAnam Anzak, Huiling Tan, Alek Pogosyan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 14, 2011
The nature of an in vivo anti-capsular polysaccharide response is markedly influenced by the composition and/or architecture of the bacterial subcapsular domainSwadhinya Arjunaraja, Paola Massari, Lee M Wetzler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 7, 2011
Adult survivors of invasive pneumococcal disease exhibit defective B cell functionTom C Darton, James B Wing, Andrew Lees, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2006
Early piribedil monotherapy of Parkinson's disease: A planned seven-month report of the REGAIN studyOlivier Rascol, Bruno Dubois, Alexandre Castro Caldas, et al.
Neuroimage|October 19, 2004
Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's diseaseShona Price, Dominic Paviour, Rachael Scahill, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 29, 2018
Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicineMargherita Fabbri, Joaquim J Ferreira, Andrew Lees, et al.
Pageof 19